1. Statins, Obesity, and Hyperlipidemia

2. Primary Prevention Trials of Lipid-Altering Therapy Including Patients With Diabetes

3. Secondary Prevention Trials of Lipid-Altering Therapy Including Patients With Diabetes

4. Statins and Risk of Incident Diabetes

5. Effect of Statins on Glucose Metabolism

6. Adiposopathy and Insulin Resistance

7. NODM Is Not a Class Effect

8. Statins, NODM, and the Liver

9. Pitavastatin Has Neutral Effect on FBG Across Dose Range

10. Different Methods of Measuring Glucose

11. Effects of Pitavastatin on Insulin Sensitivity and Liver Fat (Randomized Clinical Trial)

12. Gold Standard for Measuring Insulin Sensitivity and Liver Fat

13. Mean Baseline Characteristics

14. Results Insulin Sensitivity

15. Results Liver Fat

16. It Takes a Team

17. Conclusion

18. Abbreviations

19. Abbreviations (cont)